Download PDF
1 / Pages

Other users also viewed these articles

Current perspectives on pediatric inflammatory bowel disease focusing on transitional care management. What should we consider? Constanza Bay M; Paulina Núñez F; Rodrigo Quera; Andrés J. Yarur;
Gastroenterol Hepatol. 2023;46:139-47
De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice Alex Arenas; María José Moreta; Ingrid Ordás; Agnès Fernández-Clotet; Berta Caballol; Marta Gallego; Alejandro Vara; Rebeca Barastegui; Angel Giner; Cristina Prieto; Maria Carme Masamunt; Roberto Candia; Elena Ricart;
Gastroenterol Hepatol. 2024;47:673-82
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn¿s Disease and Ulcerative Colitis Francisco Rodríguez-Moranta; Federico Argüelles-Arias; Joaquín Hinojosa del Val; Marisa Iborra Colomino; M. Dolores Martín-Arranz; Luis Menchén Viso; Fernando Muñoz Núñez; Elena Ricart Gómez; José Germán Sánchez-Hernández; Teresa Valdés-Delgado; Jordi Guardiola Capón; Manuel Barreiro-de Acosta; Míriam Mañosa Ciria; Yamile Zabana Abdo; Ana Gutiérrez Casbas;
Gastroenterol Hepatol. 2024;47:522-52